Diagnosed with myasthenia gravis AND negative for myasthenia gravis-related antibodies OR
Diagnosed with another neuromuscular disorder that is not myasthenia gravis OR
Not diagnosed with any neuromuscular disorder
At least 21 years old
Received IVIG treatments within the last 6 weeks
Received plasma exchange withing the last 6 weeks
Received treatment with rituximab within the last 24 weeks

Age 70-95 years
Have a valid US driver's license
Drive on average 3 days a week
Willing to have camera installed in vehicle for 3 months
Alzheimers or dementia
Any reason for driving restrictions

Parent of child 6 years old or younger
none

10-18 years old
autism spectrum disorder
corrected vision and hearing at normal levels
can speak in full sentences
stable internet connection in the home
active seizure disorder in last 2 years
non-native English speaker

Age 18-85
Diagnosed with amyotrophic lateral sclerosis (ALS)
ALS Functional Rating Scale (ALSFRS-R) score > 25
Has a caregiver willing to help with study activities
Forced vital capacity (FVC) ≤ 60% predicted
ALS-related weakness for more than 3 years
History of liver disease
Kidney failure

Participants capable of reading, speaking and understanding English and of giving informed consent.
Participants between the ages of 18-29 years.
Participants must be free of visual impairment that would interfere with the use of a Fitbit Versa to receive behavioral prompts.
Participants must be willing to wear a Fitbit Versa almost continually (23.5 hours/day) for a 3 month period of time.
Participants engaging in 150 or more minutes of moderate- or greater intensity physical activity each week.
Participation in an organized program with mandated physical activity (ROTC, sport)
Participants who require an assistive device for mobility or have any other condition that may limit or prevent participation in moderate-intensity physical activity
Participants with contraindications to normal physical activity on the Physical Activity Readiness Questionnaire.
Participants with a prior diagnosis of cancer, cardiovascular disease, diabetes or metabolic syndrome.

At least 50 years old
Currently residing in Pennsylvania
Able to speak, read, and write in English
Below age 50
Not currently residing in Pennsylvania
Not able to speak, read, and write in English

We are particularly interested in small and large participants.
You must be a healthy adult aged 18 years or older.
Individuals under 18 years of age are not eligible.

No recent history (< 1 year) of injuries to Achilles tendon
No history of lower limb reconstruction or surgery
age 70 year or older
History of any previous surgery to lower limb
History of rheumatoid arthritis or other degenerative joint disease
Non English speaking
Inability to provide consent

Age 18 or older
Any gender
Newly diagnosed type 2 diabetes patient within the past 12 months
Have attended at least one diabetes education after diagnosis
Able to provide consent in English
Patients who are below 18 years
Patients who have a different type of diabetes either than type 2
Patients diagnosed with Type 2 diabetes more than 12 months
Newly diagnosed diabetes patients who have not attended diabetes self-management education

Histologically confirmed non-muscle invasive urothelial carcinoma of the bladder (Ta, T1, or Tis stage) on transurethral resection of bladder tumor (TURBT) obtained within 60 days of registration.
ECOG (WHO) performance status 0 or 1
Age ≥ 18 years old at time of consent
White blood cell count (WBC) > 3.0 K/mm3
Absolute neutrophil count (ANC) ≥ 1.5 K/mm3
Subjects with muscle-invasive (i.e. T2, T3, T4), locally advanced unresectable, or metastatic urothelial carcinoma as assessed on baseline radiographic imaging obtained within 60 days prior to study registration.
Subjects with another active second malignancy other than non-melanoma skin cancers and biochemical relapsed prostate cancer.
Subjects that have completed all necessary therapy and are considered to be at less than 30% risk of relapse are not considered to have an active second malignancy and are eligible for enrollment.
Subjects who have received the last administration of an anti-cancer therapy including chemotherapy, immunotherapy, and monoclonal antibodies ≤ 4 weeks prior to starting study drug, or who have not recovered from the side effects of such therapy.
Subjects who have had any prior radiation to the prostate or pelvis.

At least 21 years old
healthy
normal blood pressure
can perform 20 continuous min of cycling
Females who are pregnant or lactating
Smoker
blood pressure over 150/100
taking medications that affect the heart
unable to perform 20 continuous min of cycling

moderate to severe ulcerative colitis
failed prior treatment
women breast feeding or pregnant
no cancer in past 5 years
no Crohns disease

Subject must have an established Rare Coagulation Disorder diagnosis (
Must currently receive or have received care at and ATHN affiliated HTC
Subject must have opted into the ATHNdataset
Subject is unwilling to sign informed consent form

At least 21 years old
healthy
•no major medical concerns
women and men of all races
Females who are pregnant or lactating
have a chronic medical concern

The child must be age 7-8 when the first study visit is completed
The child must not have any food allergies to foods used in the study, learning disabilities, psychological diagnoses, red/green color blindness, or claustrophobia.
The child must not be taking any medications known to influence cognitive function, taste, appetite or blood flow
The child's BMI must be below the 90th percentile at the first visit
The biological mother and father must have a BMI between 18.5-25 kg/m2 (low-risk group) or greater than or equal to 30 kg/m2 for mothers and greater than or equal to 25 kg/m2 for fathers (high-risk group) and 1 parent must attend all visits.
Children will be excluded if they are not within the age requirements (< than 7 years old or > than 8 years-old at the first visit).
Children will be excluded if they have any food allergies, learning disabilities, psychological diagnoses, red/green color blindness, or claustrophobia
Children will be excluded if they are taking cold or allergy medication, or other medications known to influence cognitive function, taste, appetite, or blood flow
Children will be excluded if their BMI is above the 90th percentile at the first visit
Families will be excluded if the biological mother or father do not fit the BMI requirements

Be in a romantic relationship
Live in State College area
Has visited at least 5 places with their romantic partner(s) in State College
Have never lived in State College area
have never engaged in a romantic relationship

Child between the ages of 6 and 17
Child has a history of physical abuse, sexual abuse, or other type of maltreatment
Child displays posttraumatic stress symptoms
Primary caregiver willing to participate in treatment
Child has a developmental or intellectual delay.
Uncontrolled allergy to or fear of dogs on part of either the child or caregiver.
CHild or caregiver has a history of aggression toward animals

Age 55-75
Postmenopausal
Not taking osteoporosis medication
Normal to low bone density
Willing to add dried plums to diet
Currently using osteoporosis medication
Other medications known to impact bone health
Extremely low or high bone density

College Student
Military Veteran
Current Member of the Military
Non-Military Civilians
Under age 18

Positive for ANA (antinuclear antibodies)
Age 18 to 45 years, inclusive
Have never taken hydroxychloroquine
Previous use of immunosuppressive drugs
Diagnosis of systemic lupus erythematosus

18-55 years of age
Right Handed
Smokes cigarettes
under 18 years of age or over 55 years of age
Left Handed
non-smokers

All Genders
All races/ethincities
Participants between 18 and 25
Participants YOUNGER than 18
Participants OLDER than 25

Children 8-13 years of age
Speak and understand English
Participation of a legal guardian
Intellectual or learning disability

Healthy throwing athletes (baseball, javelin, football)
Athletes with Ulnar Collateral Ligament Injury
Ulnar Collateral Ligament Surgery
Tommy John's Surgery
Sensibility to Ultrasound Gels

Native English speaker
Normal vision and hearing (with correction)
Free of neuroneurologic, psychiatric, endocrinology disorders
Free of concussions with loss of consciousness
Family history of autism spectrum disorders (in parents or full siblings)
History of working with metal
Irremovable metallic implants in the body (e.g. braces)
Pregnancy
Weigh more than 250lbs or get claustrophobic in small spaces

18-50 years old
No known hearing impairment
No known speaking impairment
Subjects will need to be bilingual (with varying proficiency in the second language
•beginner to advanced) or monolingual
Known hearing impairment (past or present)
Known speech impairment (past or present)
Under 18 or over 50

40 years of age or older
Patient Group: Fibrotic lung disease with chronic cough symptoms or Idiopathic cough syndrome
Healthy Control Group: no cough (either chronic or acute)
Recent history of smoking (former smokers must be tobacco-free for at least 1 year)
History of (other) lung diseases
History of uncontrolled gastroesophageal reflux disease (GERD)
Use of exclusionary medications (i.e. steroids, ACE inhibitors, narcotics, cough suppressants)
History of uncontrolled post nasal drip

Men and Women aged 18-30 and 60-80 years old
Healthy weight
Not taking high cholesterol/high blood pressure medication
Non-diabetic
Tobacco use
Illegal/recreational drug use
Pregnant or breastfeeding
Allergy to latex

Scheduled for colonoscopy in the next 4 months
age 50 and older who are undergoing their first ever screening colonoscopy
adults age 70 and older with colonoscopy more than 9.5 years ago
willing to provide blood, urine and stool samples
able to tolerate removal of 5 tubes (3.5 tablespoons) of blood
positive stool blood test (FIT/FOBT) in the past year
ever had colon or rectal cancer
history of inflammatory bowel disease
confirmed hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, HIV or chronic viral hepatitis
cancer diagnosis or treatment in past year